MSF Scientific Days International 2024
MSF Scientific Days International 2024 covered topics such as the anticipated cost analysis for the TB-PRACTECAL study, scenario-based projections from Gaza, innovations in combating antimicrobial resistance, 'smart PPE' for filovirus, and findings from our inaugural mass reactive vaccination campaign, among others.
Session 1: From trials to tools: solutions for humanitarian health
Malaria Anticipation Project: development of a predictive malaria early warning system for anticipatory action in Jonglei State, South Sudan. Tom Wardley, Arup & Kim West, MSF. View the abstract | View the slides | Watch the video
Antibiogo as an innovative solution to detect antimicrobial resistance: from an operational need to a CE-marked diagnostic test available for low-income and middle-income countries. Nada Malou, MSF. View the abstract | View the slides | Watch the video
Once-weekly fosravuconazole versus daily itraconazole, with surgery, in eumycetoma patients in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial. Ahmed Fahal, Mycetoma Research Centre. View the abstract | View the slides | Watch the video
Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TBPRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis. Dzintars Gotham, Independent. View the abstract | View the slides | Watch the video
Session 2: Targeting treatment: right people, right drugs, right dose
Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review. James Wilson, University of Oxford. View the abstract | View the slides | Watch the video
Towards an arsenic-free oral treatment for human African trypanosomiasis due to T.b. rhodesiense: a new tool for disease elimination. Elisabeth Baudin, Epicentre. View the abstract | View the slides | Watch the video
Evaluation of an IS2404 LAMP protocol, a simple and rapid test for diagnosis of Buruli ulcer in lowresource settings. Astrid Erber, Medical University of Vienna. View the abstract | View the slides | Watch the video
Improving treatment of multidrug-resistant tuberculosis:results of the endTB randomised clinical trial. Lorenzo Guglielmetti, MSF. View the abstract | View the slides | Watch the video
Session 3: Mortality estimates: more than just counting deaths?
Morbidity patterns and factors associated with mortality in the Inpatient Therapeutic Feeding Centre in Abs General Hospital, Yemen: an unmatched case-control study. Su Lan Yang, MSF. View the abstract | View the slides | Watch the video
War in Gaza: scenario-based excess mortality projections. Zeina Jamaluddine, London School of Hygiene and Tropical Medicine. View the abstract | View the slides | Watch the video
Session 4: Advancements in outbreak response: protecting pregnancy, people, populations
Case-area targeted interventions to rapidly contain the spread of cholera: an observational study in the DRC. Flavio Finger, Epicentre. View the abstract | View the slides | Watch the video
A novel personal protective equipment for filovirus outbreaks:a usability study under simulated field conditions. Claire Dorion, MSF. View the abstract | View the slides | Watch the video
Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan. Etienne Gignoux, Epicentre. View the abstract | View the slides | Watch the video